Rising Drug Use Stems From Changes In Clinical Guidelines – PhRMA Report
Executive Summary
Increased use of drugs for high cholesterol is partly due to a paradigm shift from an initial approach of diet and exercise towards starting patients on drug therapy as the first course of action, according to a study on the increased use of medication for chronic conditions co-sponsored by the Pharmaceutical Research & Manufacturers of America and the Disease Management Association of America
You may also be interested in...
Combo Lipid-Lowering Drugs Will Help Drive Cholesterol Market In 2007 – IMS
Patent losses this year for blockbuster lipid-lowering agents including Merck's Zocor (simvastatin) and Bristol-Myers Squibb's Pravachol (pravastatin) will cause a six percentage point drop in growth in the class in 2007, but the advent of combination therapies are expected to help offset the negative impact, IMS Health projects
Combo Lipid-Lowering Drugs Will Help Drive Cholesterol Market In 2007 – IMS
Patent losses this year for blockbuster lipid-lowering agents including Merck's Zocor (simvastatin) and Bristol-Myers Squibb's Pravachol (pravastatin) will cause a six percentage point drop in growth in the class in 2007, but the advent of combination therapies are expected to help offset the negative impact, IMS Health projects
Vytorin Takes Low Road To Higher Ground: Lower LDL Is Key To Growth
Schering-Plough sees positioning Vytorin as the preferred cholesterol therapy for achieving lower LDL levels as the key to future growth